Home|Journals|Articles by Year|Audio Abstracts RSS - TOC

Original Research

Cardiogenic shock as a first presentation in acute myocardial infarction in Egyptian’s patients and its outcome

Adel Hamed Elbaih, Ahmed G. Elsayed, Gamela M. Nasr, Mona M. Rayan.


Cardiogenic shock secondary to acute myocardial infarction continues to be a frustrating problem of great clinical significance. With improvements in the medical management of AMI, particularly the treatment of ventricular arrhythmias, CS has emerged as the most common cause of death (7 to 12%) of all patients admitted with myocardial infarction. Was to minimise the impact of acute MI and/or its complications especially cardiogenic shock by early detection and rapid diagnosis to improve management processes. The study was descriptive, comprehensive study that included 60 patients presented with acute myocardial infarction with or without cardiogenic shock. Firstly assessed clinical, Electrocardiography and cardiac enzymes with treatment accordingly to Advanced Cardiac Life Support (ACLS) guidelines and treat the life threading conditions if present with follow-up throughout their hospital stays for Major Adverse Cardiac Events (MACE) that included death, reinfarction. The incidence of cardiogenic shock as the presenting problem in acute MI was 13.3%. The Patients with cardiogenic shock stayed more in the hospital with significantly more incidence of reinfarction and in-hospital mortality. Cases with CS were older in age, had a higher incidence of diabetes mellitus, angina, previous MI and heart failure, a larger size of infarction, as reflected in increased level of cardiac enzymes, and was found in patients with CS.

Key words: Acute myocardial infarction, cardiogenic shock, heart

Full-text options

Share this Article

Online Article Submission
• ejmanager.com
• ojshosting.net

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.